---
title: In Recent Guidance, FDA aims for Patient Safety at 503B Facilities
description: In Recent Guidance, FDA aims for Patient Safety at 503B Facilities
image: https://info.consortiex.com/hubfs/Untitled-10.jpg
---

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png "ConsortiEX")](https://www.consortiex.com)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

- [Home](https://consortiex.com/)
- Solutions 
    - [Assure-Trak® | 503B](https://consortiex.com/outsourcing-facility-503b/)
    - [Assure-Trak® | Health System](https://consortiex.com/health-system/)
    - [DSCSA Compliance](https://consortiex.com/dscsa-compliance/)
    - [Verify on Receipt™](https://consortiex.com/verify-on-receipt/)
- [ConsortiEX Blog](https://info.consortiex.com/blog)
- More 
    - [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
    - [Meet the Team](https://www.consortiex.com/meet-our-team/)
    - [Resources](https://info.consortiex.com/resources)
    - [DSCSA Resources](https://consortiex.com/dscsa-resources/)
- Contact 
    - [Current Customer Support](https://consortiex.com/support/)
    - [Request a Demo](https://consortiex.com/contact-us/)

December 17, 2018

# In Recent Guidance, FDA aims for Patient Safety at 503B Facilities

The FDA has issued a guidance to [503B](https://consortiex.com/outsourcing-facility-503b/) facilities regarding Current Good Manufacturing Practice (gCMB)

Healthcare Packaging explains:

"A Dec. 10 statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram focused on the importance of ensuring compounded product quality. FDA noted that it continues to implement its [2018 Compounding Priorities Plan](https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm592795.htm) as part of its “mission to preserve patient access to compounded drugs to meet patients’ individual medical needs while also protecting patients from the risks of contaminated or otherwise harmful products.

“Through enforcement actions, we’ve been addressing insanitary conditions and manufacturing quality issues at compounders’ facilities across the country. More activities are planned, and we’ve stepped up our collaborative work with the Department of Justice. But preventing problems before they put patient safety at risk is our key objective to protect consumers.”

In its announcement, the agency recognized that although compounded drugs “can serve an important role for certain patients whose medical needs cannot be met by an FDA-approved drug product, it’s important to understand that compounded drug products haven’t undergone FDA premarket review for safety and effectiveness. Compounders who are uniquely permitted under law to compound and distribute certain compounded drugs without receiving patient-specific prescriptions are referred to as outsourcing facilities.

“There has been a lot of discussion around the issue of “office stock” – the drugs that doctors may keep on hand for certain procedures. If certain conditions are met, the law allows outsourcing facilities to provide hospitals, physicians’ offices, and other health care facilities with supplies of compounded drugs to keep on hand as ‘office stock’ for their patients, who may need quick or emergency medication upon diagnosis.

“While this practice is permitted, outsourcing facilities must comply with certain requirements, including current good manufacturing practice (CGMP) requirements, and FDA routinely inspects outsourcing facilities to determine whether their products are manufactured appropriately. Today we’re updating some of our proposed policies related to these outsourcing facilities. Among our goals is to make it more feasible for compounding pharmacies to become outsourcing facilities.”

As part of its patient safety focus, the agency’s announcement addressed the importance of cGMP compliance in outsourcing facilities. “That is why today we’re releasing a revised [draft guidance ](http://usfoodanddrugadministrationfda.pr-optout.com/Tracking.aspx?Data=HHL%3d%3d297%3f%26JDG%3c%3b5%3b182%3d%26SDG%3c90%3a.&RE=MC&RI=1295064&Preview=False&DistributionActionID=15591&Action=Follow+Link)with recommendations for protecting patients from the risk of contaminated or otherwise substandard products produced by outsourcing facilities."

 

To read the full article, click [here](https://www.healthcarepackaging.com/article/fda-focuses-compounded-drug-quality-cgmps-outsourcing).

[FDA Issues Guidance on Verification Systems](https://info.consortiex.com/blog/fda-guidance-verification-system) [FDA Guidance Under Current Good Manufacturing Practice](https://info.consortiex.com/blog/fda-guidance-under-current-good-manufacturing-practice)

### Related Posts

## [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights)

## [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership)

## [ConsortiEX Customer Spotlight | Cape Cod Healthcare](https://info.consortiex.com/blog/consortiex-customer-spotlight-cape-cod-healthcare)

### Recent Posts

- [In Response to the FDA Announcement](https://info.consortiex.com/blog/in-response-to-the-fda)   
  October 11, 2024
- [ConsortiEX Soars to Support Dream Flights, and US Veterans](https://info.consortiex.com/blog/consortiex-supports-dream-flights)   
  August 6, 2024
- [ConsortiEX and LedgerDomain Announce Strategic Partnership](https://info.consortiex.com/blog/consortiex-and-ledgerdomain-announce-strategic-partnership)   
  March 13, 2024

### Topics

- [ConsortiEX (22)](https://info.consortiex.com/blog/tag/consortiex)
- [DSCSA (21)](https://info.consortiex.com/blog/tag/dscsa)
- [DQSA (18)](https://info.consortiex.com/blog/tag/dqsa)
- [FDA (18)](https://info.consortiex.com/blog/tag/fda)
- [Compounding (17)](https://info.consortiex.com/blog/tag/compounding)
- [batch compounding (16)](https://info.consortiex.com/blog/tag/batch-compounding)
- [drug quality and security act (16)](https://info.consortiex.com/blog/tag/drug-quality-and-security-act)
- [patient safety (16)](https://info.consortiex.com/blog/tag/patient-safety)
- [assure-trak (15)](https://info.consortiex.com/blog/tag/assure-trak)
- [Blog (14)](https://info.consortiex.com/blog/tag/blog)
- [Track and Trace (13)](https://info.consortiex.com/blog/tag/track-and-trace)
- [Drug Supply Chain Security Act (12)](https://info.consortiex.com/blog/tag/drug-supply-chain-security-act)
- [IV workflow software (12)](https://info.consortiex.com/blog/tag/iv-workflow-software)
- [Industry (12)](https://info.consortiex.com/blog/tag/industry)
- [Pharmacy IT software (11)](https://info.consortiex.com/blog/tag/pharmacy-it-software)
- [health care pharmacy (11)](https://info.consortiex.com/blog/tag/health-care-pharmacy)
- [iv workflow (11)](https://info.consortiex.com/blog/tag/iv-workflow)
- [503B (10)](https://info.consortiex.com/blog/tag/503b)
- [503A (9)](https://info.consortiex.com/blog/tag/503a)
- [compliance (9)](https://info.consortiex.com/blog/tag/compliance)
- [iv workflow management (9)](https://info.consortiex.com/blog/tag/iv-workflow-management)
- [Total Ingredient Life Cycle (8)](https://info.consortiex.com/blog/tag/total-ingredient-life-cycle)
- [enterprise resource planning (8)](https://info.consortiex.com/blog/tag/enterprise-resource-planning)
- [pedigree to patient (8)](https://info.consortiex.com/blog/tag/pedigree-to-patient)
- [pharmacy software (8)](https://info.consortiex.com/blog/tag/pharmacy-software)
- [traceability (8)](https://info.consortiex.com/blog/tag/traceability)
- [USP (7)](https://info.consortiex.com/blog/tag/usp)
- [anticipatory compounding (7)](https://info.consortiex.com/blog/tag/anticipatory-compounding)
- [assure-track (6)](https://info.consortiex.com/blog/tag/assure-track)
- [pharmaceutical compounding (6)](https://info.consortiex.com/blog/tag/pharmaceutical-compounding)
- [Spotlight (5)](https://info.consortiex.com/blog/tag/spotlight)
- [compounded sterile preparations (5)](https://info.consortiex.com/blog/tag/compounded-sterile-preparations)
- [compounded sterile productions (5)](https://info.consortiex.com/blog/tag/compounded-sterile-productions)
- [pharmacy (5)](https://info.consortiex.com/blog/tag/pharmacy)
- [pharmacy it (5)](https://info.consortiex.com/blog/tag/pharmacy-it)
- [quality assurance (5)](https://info.consortiex.com/blog/tag/quality-assurance)
- [DSCSA Compliance (4)](https://info.consortiex.com/blog/tag/dscsa-compliance)
- [EDI (4)](https://info.consortiex.com/blog/tag/edi)
- [News (4)](https://info.consortiex.com/blog/tag/news)
- [T3 Documentation (4)](https://info.consortiex.com/blog/tag/t3-documentation)
- [USP 797 (4)](https://info.consortiex.com/blog/tag/usp-797)
- [clean room (4)](https://info.consortiex.com/blog/tag/clean-room)
- [compounded IV bags (4)](https://info.consortiex.com/blog/tag/compounded-iv-bags)
- [compounded syringe (4)](https://info.consortiex.com/blog/tag/compounded-syringe)
- [drug serialization (4)](https://info.consortiex.com/blog/tag/drug-serialization)
- [order management (4)](https://info.consortiex.com/blog/tag/order-management)
- [sterile product compounding (4)](https://info.consortiex.com/blog/tag/sterile-product-compounding)
- [transaction history transaction information transa (4)](https://info.consortiex.com/blog/tag/transaction-history-transaction-information-transa)
- [DQSA - USP 797 (3)](https://info.consortiex.com/blog/tag/dqsa-usp-797)
- [DSCSA CaaS (3)](https://info.consortiex.com/blog/tag/dscsa-caas)
- [DSCSA Software (3)](https://info.consortiex.com/blog/tag/dscsa-software)
- [Drug Counterfeiting (3)](https://info.consortiex.com/blog/tag/drug-counterfeiting)
- [EPCIS (3)](https://info.consortiex.com/blog/tag/epcis)
- [Requirements (3)](https://info.consortiex.com/blog/tag/requirements)
- [drug borrow loan (3)](https://info.consortiex.com/blog/tag/drug-borrow-loan)
- [dscsa compliance as a service 3T (3)](https://info.consortiex.com/blog/tag/dscsa-compliance-as-a-service-3t)
- [exchange (3)](https://info.consortiex.com/blog/tag/exchange)
- [guidance (3)](https://info.consortiex.com/blog/tag/guidance)
- [illegitimate product (3)](https://info.consortiex.com/blog/tag/illegitimate-product)
- [pharmacy erp (3)](https://info.consortiex.com/blog/tag/pharmacy-erp)
- [suspect product (3)](https://info.consortiex.com/blog/tag/suspect-product)
- [3Ts (2)](https://info.consortiex.com/blog/tag/3ts)
- [ASHP (2)](https://info.consortiex.com/blog/tag/ashp)
- [COVID-19 (2)](https://info.consortiex.com/blog/tag/covid-19)
- [Compliance as a Service (2)](https://info.consortiex.com/blog/tag/compliance-as-a-service)
- [Compounding Pharmacy (2)](https://info.consortiex.com/blog/tag/compounding-pharmacy)
- [DSCSA service (2)](https://info.consortiex.com/blog/tag/dscsa-service)
- [DSCSA software and service (2)](https://info.consortiex.com/blog/tag/dscsa-software-and-service)
- [Data Entry (2)](https://info.consortiex.com/blog/tag/data-entry)
- [Drug supply chain transparency (2)](https://info.consortiex.com/blog/tag/drug-supply-chain-transparency)
- [Electronic Data Interchange (2)](https://info.consortiex.com/blog/tag/electronic-data-interchange)
- [Environmental monitoring (2)](https://info.consortiex.com/blog/tag/environmental-monitoring)
- [Manual T3 Conversion (2)](https://info.consortiex.com/blog/tag/manual-t3-conversion)
- [NDC tracking (2)](https://info.consortiex.com/blog/tag/ndc-tracking)
- [Passive auditing (2)](https://info.consortiex.com/blog/tag/passive-auditing)
- [Prescription tracking (2)](https://info.consortiex.com/blog/tag/prescription-tracking)
- [T3 (2)](https://info.consortiex.com/blog/tag/t3)
- [T3 Conversion (2)](https://info.consortiex.com/blog/tag/t3-conversion)
- [T3s (2)](https://info.consortiex.com/blog/tag/t3s)
- [compounded IV bag (2)](https://info.consortiex.com/blog/tag/compounded-iv-bag)
- [compounded syringes (2)](https://info.consortiex.com/blog/tag/compounded-syringes)
- [drug supply chain (2)](https://info.consortiex.com/blog/tag/drug-supply-chain)
- [drug transfers (2)](https://info.consortiex.com/blog/tag/drug-transfers)
- [dscsa deadline (2)](https://info.consortiex.com/blog/tag/dscsa-deadline)
- [fda guidance (2)](https://info.consortiex.com/blog/tag/fda-guidance)
- [patient specific compounding (2)](https://info.consortiex.com/blog/tag/patient-specific-compounding)
- [pharmacy serialization (2)](https://info.consortiex.com/blog/tag/pharmacy-serialization)
- [pharmacy supply chain (2)](https://info.consortiex.com/blog/tag/pharmacy-supply-chain)
- [product (2)](https://info.consortiex.com/blog/tag/product)
- [product identifier (2)](https://info.consortiex.com/blog/tag/product-identifier)
- [quarantine (2)](https://info.consortiex.com/blog/tag/quarantine)
- [regulation (2)](https://info.consortiex.com/blog/tag/regulation)
- [serialization (2)](https://info.consortiex.com/blog/tag/serialization)
- [sterile injectable compound (2)](https://info.consortiex.com/blog/tag/sterile-injectable-compound)
- [vaccine (2)](https://info.consortiex.com/blog/tag/vaccine)
- [503B. outsourcing facility (1)](https://info.consortiex.com/blog/tag/503b-outsourcing-facility)
- [Bar Code Medication Verification (1)](https://info.consortiex.com/blog/tag/bar-code-medication-verification)
- [Central Sterile Compounding (1)](https://info.consortiex.com/blog/tag/central-sterile-compounding)
- [Cleanroom (1)](https://info.consortiex.com/blog/tag/cleanroom)
- [Compounding Quality Act (1)](https://info.consortiex.com/blog/tag/compounding-quality-act)
- [ISMP (1)](https://info.consortiex.com/blog/tag/ismp)
- [Pharmacy Informatics (1)](https://info.consortiex.com/blog/tag/pharmacy-informatics)
- [Technology Assisted IV Workflow Software (1)](https://info.consortiex.com/blog/tag/technology-assisted-iv-workflow-software)
- [USP . USP 800 (1)](https://info.consortiex.com/blog/tag/usp-usp-800)
- [audit (1)](https://info.consortiex.com/blog/tag/audit)
- [barcode (1)](https://info.consortiex.com/blog/tag/barcode)
- [central-fill (1)](https://info.consortiex.com/blog/tag/central-fill)
- [community involvement (1)](https://info.consortiex.com/blog/tag/community-involvement)
- [compounding management system (1)](https://info.consortiex.com/blog/tag/compounding-management-system)
- [deadline (1)](https://info.consortiex.com/blog/tag/deadline)
- [draft guidance (1)](https://info.consortiex.com/blog/tag/draft-guidance)
- [drug loan borrow (1)](https://info.consortiex.com/blog/tag/drug-loan-borrow)
- [drug waste (1)](https://info.consortiex.com/blog/tag/drug-waste)
- [dynamic patient specific (1)](https://info.consortiex.com/blog/tag/dynamic-patient-specific)
- [grandfathered (1)](https://info.consortiex.com/blog/tag/grandfathered)
- [grandfathered product (1)](https://info.consortiex.com/blog/tag/grandfathered-product)
- [software (1)](https://info.consortiex.com/blog/tag/software)
- [specialty compounding (1)](https://info.consortiex.com/blog/tag/specialty-compounding)
- [verification systems (1)](https://info.consortiex.com/blog/tag/verification-systems)

See all

[![ConsortiEX](https://info.consortiex.com/hubfs/ConsortiEX_January2020%20Theme/images/ConsortiEX_2.png)](http://acc-dev.consortiex.com/)

- <https://twitter.com/ConsortiEX>
- <https://www.linkedin.com/company/10680398/>

*733 N Van Buren St, Ste 501*  
*Milwaukee, WI 53202*

*Office: (414) 231-4575*   
*Support: (888) 434-1442*

*Email: info@consortiex.com*

- [Homepage](https://www.consortiex.com/)
- [About ConsortiEX](https://www.consortiex.com/about-consortiex/)
- [Blog](https://info.consortiex.com/blog)
- [Contact Us](https://www.consortiex.com/contact-us/)
- [DSCSA Compliance](https://www.consortiex.com/dscsa-compliance/)
- [Health System](https://www.consortiex.com/health-system/)
- [Magnifier™ Analytics](https://consortiex.com/consortiex-magnifier-analytics/)
- [Outsourcing Facility 503B](https://www.consortiex.com/outsourcing-facility-503b/)
- [Resources](https://info.consortiex.com/resources)

 2025 | ConsortiEX Inc. | All Rights Reserved